a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects
Status:
COMPLETED
Trial end date:
2007-01-31
Target enrollment:
Participant gender:
Summary
Tolvaptan oral administraction phase I PK clinical trial. Two groups of healthy male subjects. One group receives single dose of Tolvaptan. The other group receives multi dose of Tolvaptan.
Phase:
PHASE1
Details
Lead Sponsor:
Otsuka Beijing Research Institute
Collaborator:
Chinese Academy of Medical Sciences, Fuwai Hospital